 Squarepoint Ops LLC acquired a new position in shares of NeuBase Therapeutics NASDAQ:NBSE in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 63,053 shares of the companys stock, valued at approximately 449,000. Squarepoint Ops LLC owned about 0.37 of NeuBase Therapeutics as of its most ... 